Walleye Capital’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Buy |
+567,223
| New | +$10.6M | 0.04% | 241 |
|
|
2025
Q1 | – | Sell |
-2,098
| Closed | -$75.6K | – | 2375 |
|
|
2024
Q4 | $75.6K | Buy |
2,098
+1,279
| +156% | +$46.1K | ﹤0.01% | 1730 |
|
|
2024
Q3 | $34.7K | Sell |
819
-55,015
| -99% | -$2.33M | ﹤0.01% | 2057 |
|
|
2024
Q2 | $2.25M | Buy |
55,834
+50,813
| +1,012% | +$2.05M | ﹤0.01% | 763 |
|
|
2024
Q1 | $178K | Buy |
+5,021
| New | +$178K | ﹤0.01% | 1852 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2985 |
|
|
2023
Q3 | – | Sell |
-215,299
| Closed | -$5.28M | – | 2964 |
|
|
2023
Q2 | $5.28M | Buy |
215,299
+161,961
| +304% | +$3.97M | 0.02% | 281 |
|
|
2023
Q1 | $2.17M | Buy |
53,338
+35,861
| +205% | +$1.46M | 0.03% | 494 |
|
|
2022
Q4 | $786K | Buy |
17,477
+8,648
| +98% | +$389K | 0.01% | 808 |
|
|
2022
Q3 | $422K | Sell |
8,829
-11,787
| -57% | -$563K | 0.01% | 1123 |
|
|
2022
Q2 | $1.22M | Buy |
20,616
+8,071
| +64% | +$478K | 0.03% | 542 |
|
|
2022
Q1 | $1.46M | Buy |
12,545
+6,566
| +110% | +$764K | 0.04% | 447 |
|
|
2021
Q4 | $900K | Sell |
5,979
-2,268
| -28% | -$341K | 0.03% | 640 |
|
|
2021
Q3 | $985 | Buy |
+8,247
| New | +$985 | 0.03% | 435 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 975 |
|
|
2019
Q2 | – | Sell |
-60
| Closed | -$4K | – | 888 |
|
|
2019
Q1 | $4K | Buy |
+60
| New | +$4K | ﹤0.01% | 353 |
|